Skip to content

effect of continuous epidural and continuous paravertebral block on pain after knee arthroplasty surgery

Comparative study of the effect of two continuous epidural methods and continuous paravertebral block on pain after knee arthroplasty surgery

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20191013045095N1
Enrollment
39
Registered
2021-09-10
Start date
2019-05-18
Completion date
Unknown
Last updated
2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative joint disease.

Interventions

Intervention 1: Control group: Epidural block group In this trial, our treatment method was performed to reduce pain after knee replacement surgery.10 to 15 cc bupivacaine is 0.25%, which is injected

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: age between 40-70 years ASA I , II having the satisfaction of participating in the study

Exclusion criteria

Exclusion criteria: sensitivity to any of the drugs used in the study Body mass index>40 severe liver and heart disease addiction or prolonged use of analgesics

Design outcomes

Primary

MeasureTime frame
Pain following joint changes leading to surgery and knee replacement. Timepoint: Immediately after the intervention 4 hours after the intervention 8 hours after the intervention 16 hours after the intervention 24 hours after the intervention. Method of measurement: Pain intensity with VAS scale numbered by a ruler on a scale of 0 to 10.

Secondary

MeasureTime frame
Age. Timepoint: 0. Method of measurement: Year.;Sex. Timepoint: 0. Method of measurement: Male or female.;Weight. Timepoint: 0. Method of measurement: Different number by kilogram.;Side effects of anesthesia. Timepoint: 24 hours. Method of measurement: Patient symptoms.;Side effects of mepridine. Timepoint: 24 hours. Method of measurement: Patient symptoms.;Amount of mepridine. Timepoint: 24 hours. Method of measurement: By used dosage.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSara zamani

Iran University of Medical Sciences

Sarazamaniaa@gmail.com+98 21 4461 6943

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026